Cover Image
Market Research Report

Expression Vectors Market by Application for Biotechnology & Pharmaceutical Companies, CROs & CMOs, and Academic Research End-user: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021

Published by Zion Market Research Product code 630251
Published Content info 110 Pages
Delivery time: 2-3 business days
Price
Back to Top
Expression Vectors Market by Application for Biotechnology & Pharmaceutical Companies, CROs & CMOs, and Academic Research End-user: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021
Published: December 21, 2016 Content info: 110 Pages
Description

The report covers detailed analysis and forecast for the expression vectors market on a global and regional level from 2015 to 2021. The study offers historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million). The study comprises a comprehensive view of the market with the review of market drivers, restraints, and opportunities. It also provides the level of impact of drivers and restraints on the expression vectors market between 2015 and 2021.

The study included a detailed competitive scenario and host portfolio of key vendors. The report evaluates Porters Five Forces model to analyze the different factors affecting the growth of the expression vectors market. Moreover, the study encompasses a market attractiveness analysis, which provides the most attractive and least attractive market segments information by the host, application, and region.

The report includes detailed segmentation of expression vectors market based on host, application, end-user and region. Bacterial, yeast, insect and mammalian are the key host in the expression vectors market. On the basis of application segment, the market can be classified into therapeutic, industrial, and research applications. The expression vectors market is segmented on the basis of different end-user such as pharmaceutical biotechnology companies, contract research organizations (CROs) contract manufacturing organizations (CMOs), and academic research institutes. Major regional segment analyzed in this report include North America, Europe, Asia-Pacific, Latin America and the Middle East Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India, and Brazil.

The report provides detailed competitive outlook including market share and company profiles of the key players operating in the global market. Some of the key participants in the report includePromega Corporation, Agilent Technologies, New England Biolabs, Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Merck Millipore, QIAGEN, Clontech Laboratories, Inc., and GenScript USA Inc.

This report segments the global expression vectors market as follows:

Global Expression Vectors Market: Host Analysis

  • Bacterial
  • Yeast
  • Insect
  • Mammalian

Global Expression Vectors Market: Application Analysis

  • Therapeutic
  • Industrial
  • Research

Global Expression Vectors Market: End-user Segment Analysis

  • Biotechnology Pharmaceutical Companies
  • Contract Research Organizations (CROs) Contract Manufacturing Organizations (CMOs)
  • Academic Research Institutes.

Global Expression vectors Market: Regional Segment Analysis

  • North America
  • U.S.
  • Europe
  • Germany
  • France
  • UK
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa
Table of Contents

Table of Contents

Chapter 1. Introduction

  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology

Chapter 2. Executive Summary

  • 2.1. Global expression vectors market, 2015 2021 USD Million)
  • 2.2. Global expression vectors market : Snapshot

Chapter 3. Expression Vectors Market Dynamics

  • 3.1. Introduction
  • 3.2. Market drivers
    • 3.2.1. Global expression vectors market drivers: Impact analysis
    • 3.2.2. Strong demand of protein-based drugs
  • 3.3. Market restraints
    • 3.3.1. Global expression vectors market restraints: Impact analysis
    • 3.3.2. High cost of protein therapy
  • 3.4. Opportunities
    • 3.4.1. Technology advancements
  • 3.5. Porters five forces analysis
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. Threat from new entrants
    • 3.5.4. Threat from new substitutes
    • 3.5.5. Degree of competition
  • 3.6. Market attractiveness analysis
    • 3.6.1. Market attractiveness analysis, by host segment
    • 3.6.2. Market attractiveness analysis, by end-user segment
    • 3.6.3. Market attractiveness analysis, by application segment
    • 3.6.4. Market attractiveness analysis, by regional segment

Chapter 4. Global Expression Vectors Market Competitive Landscape

  • 4.1. Company market share, 2015 (Subject To Data Availability)
    • 4.1.1. Global cellulose acetate market: company market share, 2015
  • 4.2. Strategic Development
    • 4.2.1. Acquisitions Mergers
    • 4.2.2. New Host Launch
    • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
    • 4.2.4. Research and Development, Host and Regional Expansion
  • 4.3. Host Portfolio
  • 4.4. Patent Analysis (2011-2016)
    • 4.4.1. Patent Trend
    • 4.4.2. Patent Share by company
    • 4.4.3. By Region

Chapter 5. Global Expression Vectors Market Host Analysis

  • 5.1. Global expression vectors market: Host overview
    • 5.1.1. Global expression vectors market revenue share, by host, 2015 - 2021
  • 5.2. Bacteria
    • 5.2.1. Global expression vectors market for bacteria, 2015 - 2021 (USD Million)
  • 5.3. Yeast
    • 5.3.1. Global expression vectors market for yeast, 2015 - 2021 (USD Million)
  • 5.4. Insect
    • 5.4.1. Global expression vectors market for insect, 2015 - 2021 (USD Million)
  • 5.5. Others
    • 5.5.1. Global expression vectors market for mammalian, 2015 - 2021 (USD Million)

Chapter 6. Global Expression Vectors Market Application Analysis

  • 6.1. Global expression vectors market: Application overview
    • 6.1.1. Global expression vectors market revenue share, by application, 2015 - 2021
  • 6.2. Therapeutic
    • 6.2.1. Global expression vectors market for therapeutic, 2015 - 2021 (USD Million)
  • 6.3. Industrial
    • 6.3.1. Global expression vectors market for industrial, 2015 - 2021 (USD Million)
  • 6.4. Research
    • 6.4.1. Global expression vectors market for research, 2015 - 2021 (USD Million)

Chapter 7. Global Expression Vectors Market End-users Analysis

  • 7.1. Global expression vectors market: end-users overview
    • 7.1.1. Global expression vectors market revenue share, by end-users, 2015 - 2021
  • 7.2. Biotechnology Pharmaceutical Companies
    • 7.2.1. Global expression vectors market for biotechnology Pharmaceutical Companies, 2015 - 2021 (USD Million)
  • 7.3. CROs CMOs
    • 7.3.1. Global expression vectors market for (CROs) (CMOs), 2015 - 2021 (USD Million)
  • 7.4. Academic Research Institutes
    • 7.4.1. Global expression vectors market for academic research Institutes, 2015 - 2021 (USD Million)

Chapter 8. Global Expression Vectors Market Regional Segment Analysis

  • 8.1. Global expression vectors market: Regional overview
    • 8.1.1. Global expression vectors market revenue share, by region, 2015 - 2021
  • 8.2. North America
    • 8.2.1. North America expression vectors market revenue, by host, 2015 - 2021 (USD Million)
    • 8.2.2. North America expression vectors market revenue, by application, 2015 - 2021 (USD Million)
    • 8.2.3. North America expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)
    • 8.2.4. U.S.
      • 8.2.4.1. U.S. expression vectors market revenue, by host, 2015 - 2021 (USD Million)
      • 8.2.4.2. U.S. expression vectors market revenue, by application, 2015 - 2021 (USD Million)
      • 8.2.4.3. U.S. expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe expression vectors market revenue, by host, 2015 - 2021 (USD Million)
    • 8.3.2. Europe expression vectors market revenue, by application, 2015 - 2021 (USD Million)
    • 8.3.3. Europe expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)
    • 8.3.4. Germany
      • 8.3.4.1. Germany expression vectors market revenue, by host, 2015 - 2021, (USD Million)
      • 8.3.4.2. Germany expression vectors market revenue, by application, 2015 - 2021, (USD Million)
      • 8.3.4.3. Germany expression vectors market revenue, by end-user, 2015 - 2021, (USD Million)
    • 8.3.5. France
      • 8.3.5.1. France expression vectors market revenue, by host, 2015 - 2021, (USD Million)
      • 8.3.5.2. France expression vectors market revenue, by application, 2015 - 2021, (USD Million)
      • 8.3.5.3. France expression vectors market revenue, by end-user, 2015 - 2021, (USD Million)
    • 8.3.6. UK
      • 8.3.6.1. UK expression vectors market revenue, by host, 2015 - 2021 (USD Million)
      • 8.3.6.2. UK expression vectors market revenue, by application, 2015 - 2021 (USD Million)
      • 8.3.6.3. UK expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific expression vectors market revenue, by host, 2015 - 2021, (USD Million)
    • 8.4.2. Asia Pacific expression vectors market revenue, by application, 2015 - 2021, (USD Million)
    • 8.4.3. Asia Pacific expression vectors market revenue, by end-user, 2015 - 2021, (USD Million)
    • 8.4.4. China
      • 8.4.4.1. China expression vectors market revenue, by host, 2015 - 2021 (USD Million)
      • 8.4.4.2. China expression vectors market revenue, by application, 2015 - 2021 (USD Million)
      • 8.4.4.3. China expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)
    • 8.4.5. Japan
      • 8.4.5.1. Japan expression vectors market revenue, by host, 2015 - 2021 (USD Million)
      • 8.4.5.2. Japan expression vectors market revenue, by application, 2015 - 2021 (USD Million)
      • 8.4.5.3. Japan expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)
    • 8.4.6. India
      • 8.4.6.1. India expression vectors market revenue, by host, 2015 - 2021 (USD Million)
      • 8.4.6.2. India expression vectors market revenue, by application, 2015 - 2021 (USD Million)
      • 8.4.6.3. India expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America expression vectors market revenue, by host, 2015 - 2021 (USD Million)
    • 8.5.2. Latin America expression vectors market revenue, by application, 2015 - 2021 (USD Million)
    • 8.5.3. Latin America expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)
    • 8.5.4. Brazil
      • 8.5.4.1. Brazil expression vectors market revenue, by host, 2015 - 2021 (USD Million)
      • 8.5.4.2. Brazil expression vectors market revenue, by application, 2015 - 2021 (USD Million)
      • 8.5.4.3. Brazil expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa expression vectors market revenue, by host, 2015 - 2021 (USD Million)
    • 8.6.2. Middle East and Africa expression vectors market revenue, by application, 2015 - 2021 (USD Million)
    • 8.6.3. Middle East and Africa expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)

Chapter 9. Company Profile

  • 9.1. Promega Corporation
    • 9.1.1. Overview
    • 9.1.2. Financials
    • 9.1.3. Product portfolio
    • 9.1.4. Business strategy
    • 9.1.5. Recent developments
  • 9.2. Agilent Technologies
    • 9.2.1. Overview
    • 9.2.2. Financials
    • 9.2.3. Product portfolio
    • 9.2.4. Business strategy
    • 9.2.5. Recent developments
  • 9.3. New England Biolabs
    • 9.3.1. Overview
    • 9.3.2. Financials
    • 9.3.3. Product portfolio
    • 9.3.4. Business strategy
    • 9.3.5. Recent developments
  • 9.4. Sigma-Aldrich Corporation
    • 9.4.1. Overview
    • 9.4.2. Financials
    • 9.4.3. Product portfolio
    • 9.4.4. Business strategy
    • 9.4.5. Recent developments
  • 9.5. Thermo Fisher Scientific
    • 9.5.1. Overview
    • 9.5.2. Financials
    • 9.5.3. Product portfolio
    • 9.5.4. Business strategy
    • 9.5.5. Recent developments
  • 9.6. Bio-Rad Laboratories
    • 9.6.1. Overview
    • 9.6.2. Financials
    • 9.6.3. Product portfolio
    • 9.6.4. Business strategy
    • 9.6.5. Recent developments
  • 9.7. Merck Millipore
    • 9.7.1. Overview
    • 9.7.2. Financials
    • 9.7.3. Product portfolio
    • 9.7.4. Business strategy
    • 9.7.5. Recent developments
  • 9.8. QIAGEN
    • 9.8.1. Overview
    • 9.8.2. Financials
    • 9.8.3. Product portfolio
    • 9.8.4. Business strategy
    • 9.8.5. Recent developments
  • 9.9. Clontech Laboratories, Inc
    • 9.9.1. Overview
    • 9.9.2. Financials
    • 9.9.3. Product portfolio
    • 9.9.4. Business strategy
  • 9.10. GenScript USA Inc
    • 9.10.1. Overview
    • 9.10.2. Financials
    • 9.10.3. Product portfolio
    • 9.10.4. Business strategy
    • 9.10.5. Recent developments
Back to Top